Advertisement
Letter to the Editor-in-Chief| Volume 21, ISSUE 2, P260-261, March 2022

US-guided versus US-assisted tandem insertion for cervical cancer: A nomenclature proposal

Published:December 31, 2021DOI:https://doi.org/10.1016/j.brachy.2021.07.009
      We read with great interest the work by Small Jr. et al. (
      • Small Jr., W.
      • YS Kim
      • C Joyce
      • et al.
      Uterine perforation during brachytherapy for cervical cancer: complications, outcomes, and best practices for forward treatment planning and management.
      ) about the outcomes of uterine perforations during cervical cancer brachytherapy procedure. Perforation was associated with increased risk of acute infection (13.6% versus 3.0% if no uterine perforation, p = 0.04). The local infections resolved without further complications or treatment delays. No increase in long-term complications or recurrence-free survival was detected. Taken in conjunction, these findings reassure that observation approach is safe after perforation if the patient remained asymptomatic.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Brachytherapy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Small Jr., W.
        • YS Kim
        • C Joyce
        • et al.
        Uterine perforation during brachytherapy for cervical cancer: complications, outcomes, and best practices for forward treatment planning and management.
        Brachytherapy. 2021; 20: 557-564
        • Pareek V.
        • Barthwal M.
        • Giridhar P.
        • et al.
        A phase III randomized trial of trans-abdominal ultrasound in improving application quality and dosimetry of intra-cavitary brachytherapy in locally advanced cervical cancer.
        Gynecol Oncol. 2021; 160: 375-378
        • Sapienza L.G.
        • Jhingran A.
        • Kollmeier M.A.
        • et al.
        Decrease in uterine perforations with ultrasound image-guided applicator insertion in intracavitary brachytherapy for cervical cancer: a systematic review and meta-analysis.
        Gynecol Oncol. 2018; 151: 573-578
        • Bayrak M.
        • Abakay C.D.
        Prevention of uterine perforation during intracavitary brachytherapy of cervical cancer.
        J Contemp Brachyther. 2021; 13: 167-171
        • Chino J.
        • Annunziata C.M.
        • Beriwal S.
        • et al.
        Radiation therapy for cervical cancer: executive summary of an ASTRO clinical practice guideline.
        Pract Radiat Oncol. 2020; 10: 220-234